MX374470B - Composición inmunogénica que comprende antígenos de micoplasma. - Google Patents

Composición inmunogénica que comprende antígenos de micoplasma.

Info

Publication number
MX374470B
MX374470B MX2015007729A MX2015007729A MX374470B MX 374470 B MX374470 B MX 374470B MX 2015007729 A MX2015007729 A MX 2015007729A MX 2015007729 A MX2015007729 A MX 2015007729A MX 374470 B MX374470 B MX 374470B
Authority
MX
Mexico
Prior art keywords
immunogenic composition
mycoplasma
hyosynoviae
hyorhinis
antigens
Prior art date
Application number
MX2015007729A
Other languages
English (en)
Other versions
MX2015007729A (es
Inventor
Arun V Iyer
Axel Neubauer
Brian Thomas Martinson
Christine Margaret Muehlenthaler
Dianna M Murphy Jordan
Original Assignee
Boehringer Ingelheim Vetmedica Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Vetmedica Gmbh filed Critical Boehringer Ingelheim Vetmedica Gmbh
Publication of MX2015007729A publication Critical patent/MX2015007729A/es
Publication of MX374470B publication Critical patent/MX374470B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/22—Urine; Urinary tract, e.g. kidney or bladder; Intraglomerular mesangial cells; Renal mesenchymal cells; Adrenal gland
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención se refiere, entre otros, a tina composición inmunogénica que comprende: a) uno o más antígenos de M. hyorhinis y uno o más antígenos de M. hyosynoviae; y b) un portador aceptable desde el punto de vista farmacéutico. Además, la presente invención se refiere a una composición inmunogénica que comprende a) uno o más antígenos de Mycoplasma de bacterias de Mycoplasma seleccionadas del grupo que consiste en M. hyorhinis, M. hyopneumoniae y M. hyosynoviae; y b) uno o más componentes de un sistema de células eucarióticas. Además, la presente invención también proporciona una composición inmunogénica obtenida mediante un método que comprende a) cultivar bacterias de Mycoplasma seleccionadas del grupo que consiste en M. hyorhinis, M. hyopneumoníae y M. hyosynoviae en un sistema de células eucarióticas con una cantidad reducida de suero; b) obtener un antígeno de las bacterias de Mycoplasma; y c) agregar un portador aceptable desde el punto de vista farmacéutico.
MX2015007729A 2012-12-28 2013-12-20 Composición inmunogénica que comprende antígenos de micoplasma. MX374470B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261747026P 2012-12-28 2012-12-28
PCT/US2013/076803 WO2014105671A1 (en) 2012-12-28 2013-12-20 Immunogenic composition comprising mycoplasma antigens

Publications (2)

Publication Number Publication Date
MX2015007729A MX2015007729A (es) 2015-09-07
MX374470B true MX374470B (es) 2025-03-06

Family

ID=49956440

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015007729A MX374470B (es) 2012-12-28 2013-12-20 Composición inmunogénica que comprende antígenos de micoplasma.

Country Status (20)

Country Link
US (2) US9878027B2 (es)
EP (2) EP2938356B1 (es)
JP (2) JP6195630B2 (es)
KR (1) KR102355614B1 (es)
CN (2) CN110227151B (es)
AR (1) AR094296A1 (es)
AU (2) AU2013370982C9 (es)
BR (1) BR112015015199B1 (es)
CA (1) CA2896293C (es)
CL (1) CL2015001659A1 (es)
DK (1) DK2938356T3 (es)
EA (1) EA038206B1 (es)
ES (1) ES2808673T3 (es)
MX (1) MX374470B (es)
MY (1) MY174818A (es)
PH (1) PH12015501335A1 (es)
SG (1) SG11201505086QA (es)
TW (1) TWI633890B (es)
UA (1) UA121097C2 (es)
WO (1) WO2014105671A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2938747T3 (da) 2012-12-28 2019-08-05 Boehringer Ingelheim Vetmedica Gmbh Fremgangsmåde til fremstilling af en mycoplasma vaccine
UA121097C2 (uk) * 2012-12-28 2020-04-10 Бьорінгер Інгельхайм Ветмедіка Гмбх Імуногенна композиція, що містить антигени мікоплазм
CN104730256B (zh) * 2015-04-03 2016-05-04 江苏省农业科学院 用于检测支原体抗体的组合物及其应用
CN113461791B (zh) * 2021-06-23 2022-05-03 湖北省农业科学院畜牧兽医研究所 猪鼻支原体外膜蛋白Mhr_0493在制备猪鼻支原体或其抗体检测试剂盒中的应用
CN113444157B (zh) * 2021-06-23 2022-05-13 湖北省农业科学院畜牧兽医研究所 猪鼻支原体外膜蛋白Mhr_0461在制备猪鼻支原体或其抗体检测试剂盒中的应用

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2909462A (en) 1955-12-08 1959-10-20 Bristol Myers Co Acrylic acid polymer laxative compositions
GB1074920A (en) 1965-04-21 1967-07-05 Pfizer & Co C Growth medium for mycoplasma pneumoniae and vaccine production
ES343655A1 (es) * 1966-07-11 1968-09-01 Research Corp Metodo para la preparacion de un inoculo para aves de co- rral.
JPS5540568B2 (es) * 1972-10-05 1980-10-18
US5338543A (en) * 1992-02-27 1994-08-16 Ambico, Inc. Thimerosal inactivated mycoplasma hyopneumoniae vaccine
US6537552B1 (en) * 1999-10-19 2003-03-25 Iowa State University Research Foundation Vaccine adjuvant
EP1260581B1 (en) 2000-03-03 2010-07-07 Juridical Foundation, The Chemo-Sero-Therapeutic Research Institute Cell usable in serum-free culture and suspension culture and process for producing virus for vaccine by using the cell
MY129765A (en) * 2000-12-19 2007-04-30 Wyeth Corp Improved mycoplasma hyopneumoniae bacterin vaccine
US7018638B2 (en) * 2000-12-19 2006-03-28 Wyeth Mycoplasma hyopneumoniae bacterin vaccine
WO2003004051A2 (en) * 2001-07-02 2003-01-16 Pfizer Products Inc. Mycoplasma hyopneumoniae vaccine and methods for reducing mycoplasma bovis pneumonia in cattle
PT1474067E (pt) * 2001-07-02 2008-11-14 Pfizer Prod Inc Vacinação numa dose com mycoplasma hyopneumoniae
TWI238721B (en) * 2003-06-20 2005-09-01 Animal Technology Inst Taiwan Swine enzootic vaccine, its producing method and usage
WO2006056841A1 (en) * 2004-11-24 2006-06-01 Pharmacia & Upjohn Company Llc Multiple-strain mycoplasma hyopneumoniae vaccines
CA2595556A1 (en) * 2005-02-09 2006-08-17 Magna International Inc. Method of manufacturing a semi-structural panel
JP4693839B2 (ja) 2005-03-10 2011-06-01 共立製薬株式会社 動物由来の成分なしで培養可能である細胞株及びその作出方法、これを用いたウイルスの生産方法、及びワクチンの生産方法
US20070009545A1 (en) * 2005-07-07 2007-01-11 Joachim Frey Mycoplasma subunit vaccine
KR101464783B1 (ko) * 2006-09-15 2014-11-26 메디뮨 엘엘씨 높은 역가로 바이러스 증식을 지원하는 ｍｄｃｋ 세포주 및 이를 이용한 생물반응기 공정
US20090068231A1 (en) 2007-09-11 2009-03-12 Wyeth Live attenuated mycoplasma strains
AR069087A1 (es) * 2007-10-29 2009-12-30 Boehringer Ingelheim Vetmed Cepa bacteriana de m. bovis atenuada avirulenta obtenida por pases, vacuna de micoplasma boris y metodos de uso de la misma
CN104043116A (zh) 2007-11-06 2014-09-17 硕腾W有限责任公司 猪肺炎支原体无毒力佐剂化活疫苗
JP5613061B2 (ja) * 2008-01-23 2014-10-22 ベーリンガー インゲルハイム フェトメディカ インコーポレイテッド Ｐｃｖ２マイコプラズマ・ハイオニューモニエ免疫原性組成物および前記組成物の製造方法
US8444989B1 (en) * 2008-04-18 2013-05-21 Boehringer Ingelheim Vetmedica Gmbh One dose vaccination against mycoplasma infections of pigs
JPWO2009142086A1 (ja) * 2008-05-23 2011-09-29 学校法人 久留米大学 マイコプラズマ感染症用ワクチン組成物
WO2009156960A2 (en) * 2008-06-27 2009-12-30 Pfizer Inc. Novel adjuvant compositions
BRPI1010679B1 (pt) 2009-05-19 2020-09-24 Bioproperties Pty Ltd Cepa de vacina de mycoplasma hyopneumoniae sensível à temperatura e aplicações da mesma, composiçao de vacina, método de preparaçao e uso da mesma
US20110150770A1 (en) * 2009-12-18 2011-06-23 Boehringer Ingelheim Vetmedica, Inc. Multivalent vaccine against porcine teschovirus and other disease causing organisms in swine
AT509622A1 (de) * 2010-04-08 2011-10-15 Greiner Bio One Gmbh Verfahren und kit zur trennung viraler und prokaryontischer von eukaryontischen nukleinsäuren
CN102258776B (zh) 2011-07-07 2013-07-10 普莱柯生物工程股份有限公司 猪肺炎支原体、猪鼻支原体二联灭活疫苗及其制备方法
UA114504C2 (uk) * 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs
US9120859B2 (en) * 2012-04-04 2015-09-01 Zoetis Services Llc Mycoplasma hyopneumoniae vaccine
UA114503C2 (uk) * 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv та mycoplasma hyopneumoniae
UA121097C2 (uk) * 2012-12-28 2020-04-10 Бьорінгер Інгельхайм Ветмедіка Гмбх Імуногенна композиція, що містить антигени мікоплазм
DK2938747T3 (da) * 2012-12-28 2019-08-05 Boehringer Ingelheim Vetmedica Gmbh Fremgangsmåde til fremstilling af en mycoplasma vaccine
UA121200C2 (uk) * 2013-09-19 2020-04-27 Зоетіс Сервісіз Ллс Ад'ювант на основі олії
CN112316129B (zh) * 2014-04-03 2025-01-28 勃林格殷格翰动物保健美国有限公司 猪流行性腹泻病毒疫苗

Also Published As

Publication number Publication date
US10758602B2 (en) 2020-09-01
MX2015007729A (es) 2015-09-07
AU2018202698B2 (en) 2020-02-13
EP2938356B1 (en) 2020-05-13
CA2896293C (en) 2023-11-07
CL2015001659A1 (es) 2016-09-16
EA038206B1 (ru) 2021-07-23
EP2938356A1 (en) 2015-11-04
CN110227151B (zh) 2024-06-14
JP2017197568A (ja) 2017-11-02
CN104981252A (zh) 2015-10-14
CN110227151A (zh) 2019-09-13
WO2014105671A1 (en) 2014-07-03
AU2013370982A1 (en) 2014-07-03
CN104981252B (zh) 2019-06-18
TWI633890B (zh) 2018-09-01
US20140186393A1 (en) 2014-07-03
CA2896293A1 (en) 2014-07-03
KR102355614B1 (ko) 2022-01-27
AU2018202698A1 (en) 2018-06-14
PH12015501335A1 (en) 2015-09-02
AU2013370982C9 (en) 2019-01-24
AR094296A1 (es) 2015-07-22
TW201438733A (zh) 2014-10-16
BR112015015199B1 (pt) 2022-09-06
DK2938356T3 (da) 2020-07-27
US9878027B2 (en) 2018-01-30
EP3730148A3 (en) 2021-03-24
BR112015015199A2 (pt) 2017-07-11
UA121097C2 (uk) 2020-04-10
AU2013370982B2 (en) 2018-02-15
KR20150100919A (ko) 2015-09-02
ES2808673T3 (es) 2021-03-01
SG11201505086QA (en) 2015-07-30
JP6195630B2 (ja) 2017-09-13
JP2016505603A (ja) 2016-02-25
US20180125957A1 (en) 2018-05-10
EA201500700A1 (ru) 2016-01-29
AU2013370982C1 (en) 2019-01-17
JP6456437B2 (ja) 2019-01-23
EP3730148A2 (en) 2020-10-28
MY174818A (en) 2020-05-17

Similar Documents

Publication Publication Date Title
EA201300915A1 (ru) Новый европейский штамм prrsv
MY173223A (en) Method of making a mycoplasma vaccine
PH12015501000A1 (en) Anti-notch3 antibodies and antibody-drug conjugates
PH12013502442A1 (en) Inactivated dengue virus vaccine
MY166792A (en) Mycoplasma Hyopneumoniae Vaccine
EA201890942A1 (ru) Мультивалентные вакцины с синтетическими наноносителями
MY170720A (en) Antibody formulations
MX2015005944A (es) Cepas microbianas, composiciones y metodos para incrementar el fosfato disponible para las plantas.
MX356337B (es) Anticuerpos contra csf-1r humano y sus usos.
MX336682B (es) Anticuerpos contra csf-1r humanos y usos de los mismos.
PH12015501101A1 (en) Method for eliciting an immune response to an immunogen
MX2014010754A (es) Composiciones que comprenden inmunoglobulinas de tipo secretor.
PH12015501335A1 (en) Immunogenic composition comprising mycoplasma antigens
UA116697C2 (uk) Композиція для запобігання зараженню видами роду mycoplasma
GB201017519D0 (en) Vaccines
MX2018005134A (es) Formulacion de factor viii (fviii).
BR112015020053B8 (pt) Composições para cuidado oral
MX352620B (es) Polimeros de condensacion de acido mandelico.
MX2013010618A (es) Metodo para preparar conjugados glucïdicos de glicopeptidos antigenicos multiples.
TW201613927A (en) Method for preparation of substituted imidazopyridazines
MX2016001694A (es) Formulacion de vacuna de sacarido.
GB2515669A (en) Bacterial vaccine
IN2013CH04378A (es)
BR112016020373A8 (pt) composição, métodos para produção de uma célula dendrítica incubada, para preparação de uma composição e para produzir uma mistura de células, e, uso de uma composição

Legal Events

Date Code Title Description
FG Grant or registration